新聞

• Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
  11.06.2021 / 19:12 - GlobeNewswire
•  
• Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human Trial
  08.03.2021 / 07:00 - GlobeNewswire
•  
• Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
  16.12.2020 / 20:51 - GlobeNewswire
•  
• Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine
  24.08.2020 / 21:22 - GlobeNewswire
•  
• Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
  22.07.2020 / 08:00 - GlobeNewswire
•  
• Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine
  01.07.2020 / 15:23 - GlobeNewswire
•  
• Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership
  18.06.2020 / 07:19 - GlobeNewswire
•  
• Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen
  12.06.2020 / 19:10 - GlobeNewswire
•  
• Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
  08.06.2020 / 07:00 - GlobeNewswire
•  
• Bavarian Nordic Enters Agreement with AdaptVac to Advance COVID-19 Vaccine Program
  06.05.2020 / 08:00 - GlobeNewswire

« Back  1  2  3  4  5  (+6...)  Next »